AMS 700™ with InhibiZone™ Penile Prosthesis
- Indication
- Chronic, organic erectile dysfunction (ED) resistant to conservative therapies; especially suitable for patients at higher infection risk (e.g., diabetes)
- Manufacturer
- Boston Scientific (formerly American Medical Systems)
- Lecheng Status
- First implant completed (May 2026) at Ruijin Hainan Hospital
- Available At
- 上海交通大学医学院附属瑞金医院海南医院
- Regulatory Status
- FDA: Approved; EMA: Approved (CE marked); NMPA: Not yet approved in mainland China
Common Questions
Who is eligible for this treatment?
Patients with confirmed indication and a treating physician referral. International patients need a medical visa (M visa).
How can I access this treatment in Lecheng?
Contact the hospital listed in the quick facts section. International patients can use medical agents or contact the hospital directly.
What is the cost of treatment?
Costs vary by treatment protocol and length of stay. Please contact the hospital for accurate pricing. International insurance may be accepted.
Indication: Chronic, organic erectile dysfunction (ED) resistant to conservative therapies; especially suitable for patients at higher infection risk (e.g., diabetes)
Manufacturer: Boston Scientific (formerly American Medical Systems)
The world's only clinically proven penile prosthesis that significantly reduces post-surgical infection rates. Three-piece inflatable design with proprietary InhibiZone™ antibiotic impregnation technology. Creates a protective antimicrobial zone around the device. Current ED treatments in China (oral drugs, injections, vacuum devices) have significant limitations for many patients.
Sources & Citations
- hainanlecheng.com · accessed 2026-07-03